VentriPoint Diagnostics Ltd (VPTDF)
0.167
+0.01
(+4.29%)
USD |
OTCM |
May 31, 16:00
VentriPoint Diagnostics Net Income (Quarterly): -0.9087M for Dec. 31, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.9087M |
| September 30, 2023 | -0.875M |
| June 30, 2023 | -0.829M |
| March 31, 2023 | -0.9943M |
| December 31, 2022 | -0.813M |
| September 30, 2022 | -1.076M |
| June 30, 2022 | -1.06M |
| March 31, 2022 | -0.7963M |
| December 31, 2021 | -0.87M |
| September 30, 2021 | -0.5803M |
| June 30, 2021 | -0.4986M |
| March 31, 2021 | -1.137M |
| December 31, 2020 | -0.3854M |
| September 30, 2020 | -0.4725M |
| June 30, 2020 | -0.233M |
| March 31, 2020 | -0.6006M |
| December 31, 2019 | -0.4691M |
| September 30, 2019 | -0.4111M |
| June 30, 2019 | -0.6436M |
| March 31, 2019 | -0.9766M |
| December 31, 2018 | -0.7468M |
| September 30, 2018 | -0.0883M |
| June 30, 2018 | -0.7212M |
| March 31, 2018 | -0.0398M |
| December 31, 2017 | -1.386M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.0998M |
| June 30, 2017 | 1.368M |
| March 31, 2017 | -2.992M |
| December 31, 2016 | -0.1746M |
| September 30, 2016 | -0.5568M |
| June 30, 2016 | -0.7536M |
| March 31, 2016 | -0.4964M |
| December 31, 2015 | -0.0506M |
| September 30, 2015 | -0.7465M |
| June 30, 2015 | -0.5468M |
| March 31, 2015 | -0.4124M |
| December 31, 2014 | -0.2135M |
| September 30, 2014 | -0.5291M |
| June 30, 2014 | -0.7977M |
| March 31, 2014 | -0.4054M |
| December 31, 2013 | 0.9956M |
| September 30, 2013 | -1.528M |
| June 30, 2013 | -0.7154M |
| March 31, 2013 | -0.3816M |
| December 31, 2012 | -0.9041M |
| September 30, 2012 | -1.010M |
| June 30, 2012 | -1.496M |
| March 31, 2012 | -0.8413M |
| December 31, 2011 | 0.045M |
| September 30, 2011 | -1.804M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-1.137M
Minimum
Mar 2021
-0.233M
Maximum
Jun 2020
-0.7186M
Average
-0.7963M
Median
Mar 2022
Net Income (Quarterly) Benchmarks
| Delcath Systems Inc | -11.11M |
| Star Equity Holdings Inc | -2.224M |
| Exact Sciences Corp | -110.23M |
| CytoSorbents Corp | -6.358M |
| Progyny Inc | 16.90M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0304M |
| Total Expenses (Quarterly) | 0.942M |
| EPS Diluted (Quarterly) | -0.0073 |
| Enterprise Value | 25.32M |
| Gross Profit Margin (Quarterly) | 99.95% |
| Profit Margin (Quarterly) | -2.99K% |
| Earnings Yield | -17.74% |
| Normalized Earnings Yield | -17.69 |